CCL Products (India) Ltd

CCL Products (India) Limited announced that 4,200 equity shares with a face value of Rs 2 each were exercised by an eligible employee under the “CCL Employee Stock Option Scheme – 2022,” with the shares being issued from CCL Employees Trust, effective August 3, 2026, and ranking pari-passu with existing shares, resulting in no change to the company's paid-up share capital of Rs 26,70,55,840 divided into 13,35,27,920 shares.

CCL Products (India) Ltd announced that ICRA Limited has assigned ratings to its various debt instruments, including a rating of [ICRA] AA (Stable) for the fund based - others amounting to 1125.80, a rating of [ICRA] AA (Stable) for the fund based – Term Loan of 29.20, a rating of [ICRA] A1+ for the non-fund based - Others of 45.00, and a rating of [ICRA] AA(Stable) for the long-term - Fund -based - Term loan of 29.20, the long-term - Fund-based - Others of 1,125.80, and the short -term - Non -fund based - Others of 45.00, all under RBI; further ratings were assigned to State Bank of India Fund Based Limits (325.00), Citibank N.A. Fund Based Limits (130.00), ICICI Bank Limited Fund Based Limits (135.00 and 70.00), HDFC Bank Limited Fund Based Limits (90.80 and 90.00), Axis Bank Limited Fund Based Limits (90.00), JP Morgan Bank Fund Based Limits (130.00), DBS Bank Limited Fund Based Limits (10.00), State Bank of India Non Fund -Based Facilities (35.00), HDFC Bank Limited Non Fund -Based Facilities (10.00), and Shinhan Bank Term Loans (29.20), all carrying a rating of [ICRA] AA(Stable) and maturing on July 21, 2026, with no enhancements, assignments, or withdrawals noted.

CCL Products (India) announced that the 65th Annual General Meeting(AGM) of the company will be held on 8 September 2026.

Net profit of CCL Products (India) rose 61.33% to Rs 116.88 crore in the quarter ended June 2026 as against Rs 72.45 crore during the previous quarter ended June 2025. Sales rose 13.72% to Rs 1200.45 crore in the quarter ended June 2026 as against Rs 1055.64 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1200.451055.64 14 OPM %16.1215.06 - PBDT168.03127.74 32 PBT129.0294.19 37 NP116.8872.45 61 Powered by Capital Market - Live

CCL Products (India) has allotted 2,000 equity shares under ESOS on 21 July 2026. Post allotment, the paid up equity share capital has increased to Rs. 26,70,55,840/- divided into 13,35,27,920 of Rs. 2/- each.

CCL Products (India) will hold a meeting of the Board of Directors of the Company on 27 July 2026.

CCL Products (India) has allotted 2,100 equity shares under ESOS on 13 July 2026. With this allotment, the paid up equity share capital has increased to Rs. 26,70,55,840/- divided into 13,35,27,920 of Rs. 2/- each.

Pfizer Ltd, Syngene International Ltd, Caplin Point Laboratories Ltd, Devyani International Ltd are among the other stocks to see a surge in volumes on NSE today, 08 June 2026.CCL Products (India) Ltd recorded volume of 36.98 lakh shares by 14:14 IST on NSE, a 25.04 times surge over two-week average daily volume of 1.48 lakh shares. The stock gained 6.11% to Rs.1,145.00. Volumes stood at 1.47 lakh shares in the last session.Pfizer Ltd witnessed volume of 1.84 lakh shares by 14:14 IST on NSE, a 10.43 times surge over two-week average daily volume of 17667 shares. The stock increased 1.56% to Rs.4,526.00. Volumes stood at 28646 shares in the last session.Syngene International Ltd registered volume of 49.23 lakh shares by 14:14 IST on NSE, a 8.54 fold spurt over two-week average daily volume of 5.77 lakh shares. The stock rose 3.28% to Rs.448.50. Volumes stood at 2.89 lakh shares in the last session.Caplin Point Laboratories Ltd saw volume of 5.15 lakh shares by 14:14 IST on NSE, a 5.42 fold spurt over two-week average daily volume of 94862 shares. The stock increased 4.52% to Rs.2,125.00. Volumes stood at 84426 shares in the last session.Devyani International Ltd clocked volume of 45.46 lakh shares by 14:14 IST on NSE, a 5.06 times surge over two-week average daily volume of 8.98 lakh shares. The stock lost 1.31% to Rs.111.65. Volumes stood at 8.52 lakh shares in the last session.Powered by Capital Market - Live

CCL Products (India) has allotted 88,027 equity shares under ESOS on 04 June 2026. Post allotment, the paid up equity share capital has increased to Rs. 26,70,55,840/- divided into 13,35,27,920 of Rs. 2/- each.

CCL Products (India) announced that the Board of Directors of the Company at its meeting held on 7 May 2026, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 150%) , subject to the approval of the shareholders.